查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1590820

基因組學市場：按產品和服務、技術、最終用戶、應用分類 - 全球預測 2025-2030

Genomics Market by Product & Service (Consumables, Services, Systems & Software), Technology (Microarray, Nucleic Acid Extraction & Purification, PCR), End-User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年基因體學市值為273.6億美元，預計2024年將達到315.1億美元，複合年成長率為15.63%，到2030年將達到756.3億美元。

基因組學市場包括基因組定序、分析和編輯技術的研究、開發和應用。它對於個人化醫療、農業進步和生物技術創新至關重要。對基因組學的需求在於其透過實現精確的醫療干預、預測疾病易感性和開發標靶治療來徹底改變醫療保健的潛力。它不僅應用於醫療保健，也應用於基因工程、生物多樣性保護、法醫學等領域。新的最終用途領域包括製藥公司、研究實驗室、學術機構和生物技術公司。推動市場成長的主要因素包括定序技術的進步、定序成本的降低以及個人化醫療需求的增加。此外，政府支持基因組研究的措施以及研究機構和主要市場參與者之間合作的激增正在進一步刺激該市場。潛在的機會包括在醫療保健基礎設施現代化的開發中國家進行擴張，以及人工智慧和機器學習的整合以提高基因組資料分析的準確性和速度。基因組學市場面臨的挑戰包括對遺傳資料隱私的倫理擔憂、監管障礙和資料管理的複雜性。此外，缺乏基因組學技術方面的熟練專業人員可能會減緩市場成長。 CRISPR 技術、新型療法和消費者友善基因組檢測套組開發的創新和研究為業務成長提供了一條充滿希望​​的道路。專注於提高資料安全性、改進生物資訊學工具以及建立強大的遺傳資料管理框架的公司可能會發現顯著的戰略優勢。市場動態是充滿活力和競爭的，其特點是技術快速進步和不斷有新進入者。建立策略夥伴關係、解決道德問題以及投資於技能人才開拓是利用這一新興市場機會的推薦策略。

主要市場統計
基準年[2023] 273.6億美元
預測年份 [2024] 315.1億美元
預測年份 [2030] 756.3億美元
複合年成長率（%） 15.63%

市場動態：揭示快速發展的基因組市場的關鍵市場洞察

供需的動態交互作用正在改變基因組學市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 增加政府對基因組計劃研究和開發的資助
    • 擴大基因組醫學和精準公共衛生的採用
    • 農業基因組學遺傳工具的開發
  • 市場限制因素
    • 設備和耗材高成本
  • 市場機會
    • 新生兒基因篩檢計畫和定序技術的發展
    • 採用先進的運算技術推出創新產品與服務
  • 市場挑戰
    • 缺乏熟練和訓練有素的人員

波特的五力：駕馭基因組市場的策略工具

波特的五力架構是了解基因體學市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解基因組市場的外部影響

外部宏觀環境因素在塑造基因組學市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解基因體學市場的競爭格局

對基因組學市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣基因組市場供應商績效評估

FPNV定位矩陣是評估基因組學市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議 繪製您在基因組學市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，基因組學市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加政府對基因組計劃研究和開發的資助
      • 擴大基因組醫學和精準公共衛生的引進
      • 農業基因組學遺傳工具的開發
    • 抑制因素
      • 設備及耗材成本高
    • 機會
      • 新生兒基因篩檢計畫和定序技術的發展
      • 採用先進的運算技術推出創新產品與服務
    • 任務
      • 技術熟練且訓練有素的人員數量有限
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 基因組學市場：依產品/服務分類

  • 消耗品
  • 服務
  • 系統及軟體

第7章 基因組學市場：依技術分類

  • 微陣列
  • 核酸萃取精製
  • PCR
  • 定序

第 8 章 基因組學市場：依最終使用者分類

  • 政府機構
  • 醫院/診所
  • 製藥和生物技術公司
  • 研究中心和學術

第9章基因組學市場：依應用分類

  • 農業和動物研究
  • 診斷
  • 藥物發現與開發

第10章美洲基因組市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太基因體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的基因組市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議

公司名單

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biomatters Limited
  • Bionano Genomics, Inc.
  • C2i Genomics
  • Congenica Ltd.
  • Danaher Corporation
  • Dante Labs Inc.
  • Eagle Genomics
  • Eppendorf SE
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Fabric Genomics, Inc.
  • Helix OpCo, LLC
  • Merck & Co., Inc.
  • Myriad Genetics, Inc.
  • Nest Health Tech Inc.
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • Personalis, Inc.
  • QIAGEN GmbH
  • Quest Diagnostics Incorporated
  • Rapid Genomics by LGC Biosearch Technologies
  • Thermo Fisher Scientific Inc.
  • Vizgen, Inc.
Product Code: MRR-434CCDA04CD1

The Genomics Market was valued at USD 27.36 billion in 2023, expected to reach USD 31.51 billion in 2024, and is projected to grow at a CAGR of 15.63%, to USD 75.63 billion by 2030.

The genomics market encompasses the research, development, and application of technologies that deal with the sequencing, analysis, and editing of genomes. It is integral for personalized medicine, agricultural advancements, and biotechnology innovations. The necessity of genomics lies in its potential to revolutionize healthcare by enabling precise medical interventions, predicting disease susceptibility, and developing targeted therapies. Beyond healthcare, its application extends to areas such as genetic engineering, biodiversity conservation, and forensic science. Emerging end-use sectors include pharmaceutical companies, research centers, academic institutions, and biotechnological companies. Key factors driving market growth include advancements in sequencing technologies, decreasing costs of sequencing, and an increasing demand for personalized medicine. Additionally, government initiatives supporting genomic research and a surge in collaborations between research institutions and key market players further stimulate this market. Potential opportunities include expansion in developing countries where healthcare infrastructure modernization is underway and the integration of AI and machine learning to enhance genomic data analysis accuracy and speed. Challenges facing the genomics market include ethical concerns over genetic data privacy, regulatory hurdles, and the complexity of data management. Furthermore, a lack of skilled professionals in genomics technology can slow market growth. Innovations and research in CRISPR technologies, novel therapeutics, and the development of consumer-friendly genomic testing kits present promising avenues for business growth. Companies focusing on improving data security, advancing bioinformatics tools, and establishing robust frameworks for genetic data management are likely to find significant strategic advantages. The nature of the genomics market is dynamic and highly competitive, characterized by rapid technological advancements and continuous new entrants. Building strategic partnerships, addressing ethical concerns, and investing in skilled workforce development are recommended strategies for leveraging opportunities in this evolving market.

KEY MARKET STATISTICS
Base Year [2023] USD 27.36 billion
Estimated Year [2024] USD 31.51 billion
Forecast Year [2030] USD 75.63 billion
CAGR (%) 15.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genomics Market

The Genomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of government funding for the R&D in genome projects
    • Growing adoption of genomic medicine and precision public health
    • Development of genetic tools in agrigenomics
  • Market Restraints
    • High cost of equipment and consumables
  • Market Opportunities
    • Growth of newborn genetic screening programs and sequencing technologies
    • Adoption of advanced computational technologies to launch innovative products and services
  • Market Challenges
    • Limited skilled and trained personnel

Porter's Five Forces: A Strategic Tool for Navigating the Genomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genomics Market

A detailed market share analysis in the Genomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genomics Market

A strategic analysis of the Genomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Biomatters Limited, Bionano Genomics, Inc., C2i Genomics, Congenica Ltd., Danaher Corporation, Dante Labs Inc., Eagle Genomics, Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Fabric Genomics, Inc., Helix OpCo, LLC, Merck & Co., Inc., Myriad Genetics, Inc., Nest Health Tech Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Personalis, Inc., QIAGEN GmbH, Quest Diagnostics Incorporated, Rapid Genomics by LGC Biosearch Technologies, Thermo Fisher Scientific Inc., and Vizgen, Inc..

Market Segmentation & Coverage

This research report categorizes the Genomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Consumables, Services, and Systems & Software.
  • Based on Technology, market is studied across Microarray, Nucleic Acid Extraction & Purification, PCR, and Sequencing.
  • Based on End-User, market is studied across Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Centers & Academic.
  • Based on Application, market is studied across Agriculture & Animal Research, Diagnostics, and Drug Discovery & Development.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of government funding for the R&D in genome projects
      • 5.1.1.2. Growing adoption of genomic medicine and precision public health
      • 5.1.1.3. Development of genetic tools in agrigenomics
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of equipment and consumables
    • 5.1.3. Opportunities
      • 5.1.3.1. Growth of newborn genetic screening programs and sequencing technologies
      • 5.1.3.2. Adoption of advanced computational technologies to launch innovative products and services
    • 5.1.4. Challenges
      • 5.1.4.1. Limited skilled and trained personnel
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Genomics Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Services
  • 6.4. Systems & Software

7. Genomics Market, by Technology

  • 7.1. Introduction
  • 7.2. Microarray
  • 7.3. Nucleic Acid Extraction & Purification
  • 7.4. PCR
  • 7.5. Sequencing

8. Genomics Market, by End-User

  • 8.1. Introduction
  • 8.2. Government Institutes
  • 8.3. Hospitals & Clinics
  • 8.4. Pharmaceutical & Biotechnology Companies
  • 8.5. Research Centers & Academic

9. Genomics Market, by Application

  • 9.1. Introduction
  • 9.2. Agriculture & Animal Research
  • 9.3. Diagnostics
  • 9.4. Drug Discovery & Development

10. Americas Genomics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Genomics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Genomics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Biomatters Limited
  • 5. Bionano Genomics, Inc.
  • 6. C2i Genomics
  • 7. Congenica Ltd.
  • 8. Danaher Corporation
  • 9. Dante Labs Inc.
  • 10. Eagle Genomics
  • 11. Eppendorf SE
  • 12. Eurofins Scientific SE
  • 13. F. Hoffmann-La Roche AG
  • 14. Fabric Genomics, Inc.
  • 15. Helix OpCo, LLC
  • 16. Merck & Co., Inc.
  • 17. Myriad Genetics, Inc.
  • 18. Nest Health Tech Inc.
  • 19. Novogene Co., Ltd.
  • 20. Oxford Nanopore Technologies PLC
  • 21. Pacific Biosciences of California, Inc.
  • 22. Personalis, Inc.
  • 23. QIAGEN GmbH
  • 24. Quest Diagnostics Incorporated
  • 25. Rapid Genomics by LGC Biosearch Technologies
  • 26. Thermo Fisher Scientific Inc.
  • 27. Vizgen, Inc.

LIST OF FIGURES

  • FIGURE 1. GENOMICS MARKET RESEARCH PROCESS
  • FIGURE 2. GENOMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. GENOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. GENOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENOMICS MARKET SIZE, BY SYSTEMS & SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENOMICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENOMICS MARKET SIZE, BY NUCLEIC ACID EXTRACTION & PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENOMICS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENOMICS MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENOMICS MARKET SIZE, BY RESEARCH CENTERS & ACADEMIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. GENOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. GENOMICS MARKET, FPNV POSITIONING MATRIX, 2023